Palatin Technologies
PTN
#10644
Rank
HK$0.11 B
Marketcap
HK$62.99
Share price
-1.42%
Change (1 day)
N/A
Change (1 year)

Palatin Technologies (PTN) - Total assets

Total assets on the balance sheet as of March 2026 : HK$0.10 Billion

According to Palatin Technologies's latest financial reports the company's total assets are HK$0.10 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Palatin Technologies - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-06-30HK$25.64 M-69.43%
2024-06-30HK$83.88 M-40.33%
2023-06-30HK$0.14 B-50.34%
2022-06-30HK$0.28 B-45.83%
2021-06-30HK$0.52 B-20.74%
2020-06-30HK$0.65 B-19.43%
2019-06-30HK$0.81 B167.19%
2018-06-30HK$0.30 B-30.98%
2017-06-30HK$0.44 B426.59%
2016-06-30HK$84.25 M-63.12%
2015-06-30HK$0.22 B134.72%
2014-06-30HK$97.33 M-49.95%
2013-06-30HK$0.19 B365.91%
2012-06-30HK$41.73 M-74.67%
2011-06-30HK$0.16 B70.76%
2010-06-30HK$96.49 M-5.67%
2009-06-30HK$0.10 B-31.4%
2008-06-30HK$0.14 B-55.4%
2007-06-30HK$0.33 B7.5%
2006-06-30HK$0.31 B13.83%
2005-06-30HK$0.27 B26.05%
2004-06-30HK$0.21 B22.35%
2003-06-30HK$0.17 B83.8%
2002-06-30HK$96.39 M-13.25%
2001-06-30HK$0.11 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
HK$1.575 T 1,518,912.80%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$893.91 B 861,997.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$38.46 B 36,997.08%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
HK$0.33 B 222.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$12.01 B 11,484.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
HK$11.14 B 10,651.89%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
HK$46.98 M-54.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
HK$3.95 B 3,714.71%๐Ÿ‡บ๐Ÿ‡ธ USA